Finding the best prices at pharmacies near you...

Prescription & Medication Blog

At RxSpark we believe prescription drugs and medication should be accessible and affordable for all Americans. In addition to the savings, discounts, and convenience that RxSpark provides, the RxSpark Blog is here to bring you information, news, current events, and important upates on topics that affect healthcare and prescription drugs. Be sure to check back frequently for updates, and if you find any information that is particularly helpful please don't hesitate to share!



HCV treatment with 98% cure rate gets FDA nod

The US Food and Drug Administration (FDA) approved the hepatitis C virus (HCV) treatment Mavyret (glecaprevir, pibrentasvir), granting biopharmaceutical firm AbbVie Breakthrough Therapy Designation and Priority Review for the treatment of GT1 HCV patients not cured with prior direct-acting...

Read More

Merck diabetes drug Lusduna Nexvue gains tentative FDA approval

Pharmaceutical giant Merck has been granted tentative approval for Lusduna Nexvue (insulin glargine injection) 100 units/mL by the US Food and Drug Administration.  The follow-on biologic basal insulin comes in a pre-filled dosing device and will be used to treat patients with type 2...

Read More

Gilead's hepatitis C drug Vosevi gains FDA approval

A new hepatitis C virus (HCV) treatment is expected to appear in pharmacies soon following US Food and Drug Administration's (FDA) decision to approve Vosevi, an HCV treatment developed by Gilead Sciences, Inc. The drug was cleared to treat adults with chronic HCV genotypes 1-6 with no cirrhosis,...

Read More

US home-based medication errors 'increased by 100%'

The rate of medication errors among US residents has increased by more than 100 percent in recent years, according to a study conducted by The Center for Injury Research and Policy and the Central Ohio Poison Center at Nationwide Children’s Hospital and published in Clinical Toxicology. The...

Read More

5 Common Sports-Related Injuries and Treatment Options

Sporting injuries or those caused during physical activity and exercise are among the most common in the US, particularly among the nation's children. Figures from the National SAFE KIDS Campaign and American Academy of Pediatrics suggest around 3.5 million sporting injuries are suffered by kids...

Read More

WHO: New antibiotics needed to treat drug-resistant gonorrhea

The World Health Organization (WHO) has warned antibiotic resistance is making gonorrhea harder to treat, suggesting a heightened need to develop new antibiotics. It brought together data from 77 countries around the world, which revealed the common sexually transmitted disease (STD) is...

Read More

Diabetic patients warned about NovoPen Echo recall

Novo Nordisk has announced a recall of six batches of the insulin cartridge holders used in its NovoPen Echos due to the possibility they will crack or break when exposed to certain chemicals. The company revealed some cleaning agents may contain agents that could leave the device susceptible to...

Read More

Prescription drug costs 'a burden for a quarter of 50-80 year-olds'

More than one-quarter (27 percent) of patients between 50 and 80 years of age find the cost of their prescription medication a burden, according to the latest National Poll on Healthy Aging conducted by the University of Michigan. The study looked at responses from approximately 2,000 people within...

Read More

FDA approves first new sickle cell disease treatment in 20 years

Patients with sickle cell disease will soon have access to a new treatment following the US Food and Drug Administration's (FDA) approval of Endari (L-glutamine oral powder). The drug was cleared for use in reducing some of the serious complications often experienced by patients aged five years of...

Read More

FDA launches 90-day plan to address orphan drug backlog

The US Food and Drug Administration (FDA) has unveiled a 90-day plan to address the backlog of around 200 orphan drug designation requests that have been pending for more than 120 days. The regulatory body aims to complete reviews of all requests in this category by September 21st 2017 and plans to...

Read More